Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal sufentanil and midazolam for gastroscopy sedation
ChiCTR-OPD-17010492Phase 4Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Jan 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sufentanil and midazolam, sponsored by Beijing Friendship Hospital. Primary endpoints: respiratory rate, oxygen saturation and 1 more. Started Jan 2017; status: recruiting.
02
Drugs
sufentanilmidazolam
Beyond the preview
Go deeper on ChiCTR-OPD-17010492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPD-17010492.